US opens criminal probe into alleged lapses at Eli Lilly plant
US opens criminal probe into alleged lapses at Eli Lilly plant
Stay updated with breaking news from Action Indicated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US opens criminal probe into alleged lapses at Eli Lilly plant
Marisa TaylorMike SpectorDan Levine 1/2 Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo Read More The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (LLY.N) focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giantâs COVID-19 therapy and other drugs, three people familiar with the matter said. The probe represents a significant escalation of the government scrutiny on Lilly...
Exclusive: U.S. opens criminal probe into alleged lapses at Eli Lilly plant - sources By Marisa Taylor, Mike Spector and Dan Levine Reuters (Reuters) - The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant's COVID-19 therapy and other drugs, three people familiar with the matter said. The probe represents a significant escalation of the government scrutiny on Lilly. The pharmaceutical company, one of the worl...
Healthcare & PharmaceuticalsEXCLUSIVE Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Marisa TaylorDan Levine 9 minute read An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar Eli Lilly & Co (LLY.N) employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmakerâs COVID-19 treatment, according to an internal Lilly complaint and a sour...
Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Reuters 3 hrs ago By Dan Levine and Marisa Taylor © Reuters/MIKE SEGAR FILE PHOTO: FILE PHOTO: FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey By Dan Levine and Marisa Taylor Popular Searches (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatmen...